WebPhesgo 600-600mg-20,000units vial Phesgo 1,200-600mg-30,000units vial Directions for use: Dose: Quantity: Duration of therapy: ... Prescriber’s office stock (billing on a medical claim form) Other (please specify): Retail pharmacy Home Health / Home Infusion vendor ** Cigna’s nationally preferred specialty pharmacy WebWhat does PHESGO treat? PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for:. use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or …
Pertuzumab, Trastuzumab, and Hyaluronidase (Phesgo) - Chemocare
WebMar 2, 2024 · Phesgo is a cancer medicine for treating adults with ‘HER2-positive’ breast cancer (where a protein called HER2 is found on the cancer cells). It is used in combination with other cancer medicines in: patients with early breast cancer (when the cancer has not spread to other parts of the body) at high risk of coming back, after they have ... WebMay 2, 2024 · VI. Billing Code/Availability Information HCPCS Code: J9316 – Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg; 1 billable unit = 10 mg NDC(s): Phesgo (1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase per 15 mL) single-dose vial: 50242-0245-xx hypixel explosive bow
Phesgo CCRD Prior Authorization Form - Cigna
WebPHESGO Sample Coding. This coding information may assist you as you complete the payer forms for PHESGO. These tables are provided for informational purposes only. Please … WebPHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive). WebMost common side effects of PHESGO and tips you can try. The most common side effects of PHESGO when given with chemotherapy as part of an early breast cancer regimen are hair loss, nausea, diarrhea, low levels of red blood cells, and weakness. The most common side effects of PHESGO when given with docetaxel for treatment of breast cancer that has … hypixel failed to authenticate